Page 80 - Read Online

Calinescu et al. Hepatoma Res 2021;7:59 https://dx.doi.org/10.20517/2394-5079.2021.26 Page 15 of 17

40. Fuchs J, Seitz G, Ellerkamp V, et al. Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in
pediatric solid tumors. Surg Oncol 2008;17:323-30. DOI PubMed
41. Gupta AA, Gerstle JT, Ng V, et al. Critical review of controversial issues in the management of advanced pediatric liver tumors.
Pediatr Blood Cancer 2011;56:1013-8. DOI PubMed
42. Takahashi N, Yamada Y, Hoshino K, et al. Living donor liver re-transplantation for recurrent hepatoblastoma in the liver graft
following complete eradication of peritoneal metastases under indocyanine green fluorescence imaging. Cancers (Basel)
2019;11:730. DOI PubMed PMC
43. Kalicinski P, Ismail H, Broniszczak D, et al. Non-resectable hepatic tumors in children - role of liver transplantation. Ann Transplant
2008;13:37-41. PubMed
44. Namgoong JM, Choi JU, Hwang S, Oh SH, Park GC. Pediatric living donor liver transplantation with homograft replacement of
retrohepatic inferior vena cava for advanced hepatoblastoma. Ann Hepatobiliary Pancreat Surg 2019;23:178-82. DOI PubMed
PMC
45. Hort A, Karpelowsky J, Shun A, Thomas G. Use of a donor iliac vein graft for reconstruction of the inferior vena cava in liver
transplantation for hepatoblastoma with caval extension. Pediatr Transplant 2019;23:e13409. DOI PubMed
46. Chardot C, Saint Martin C, Gilles A, et al. Living-related liver transplantation and vena cava reconstruction after total hepatectomy
including the vena cava for hepatoblastoma. Transplantation 2002;73:90-2. DOI PubMed
47. Hasegawa T, Kimura T, Ihara Y, et al. Living-related liver transplantation with removal of inferior vena cava for unresectable
hepatoblastoma. Pediatr Transplant 2006;10:521-4. DOI PubMed
48. Uchida H, Fukuda A, Sasaki K, et al. Benefit of early inflow exclusion during living donor liver transplantation for unresectable
hepatoblastoma. J Pediatr Surg 2016;51:1807-11. DOI PubMed
49. Herden U, Grabhorn E, Lenhartz H, Kütemeier R, Fischer L. Excellent outcome following liver transplantation for hepatoblastoma
using an extensive en bloc hepatectomy technique. Transplant Proc 2019;51:1887-91. DOI PubMed
50. Kueht M, Thompson P, Rana A, Cotton R, O'Mahony C, Goss J. Effects of an early referral system on liver transplantation for
hepatoblastoma at Texas Children's Hospital. Pediatr Transplant 2016;20:515-22. DOI PubMed
51. Venkatramani R, Stein JE, Sapra A, et al. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br
J Surg 2015;102:108-13. DOI PubMed
52. Ruth ND, Kelly D, Sharif K, Morland B, Lloyd C, McKiernan PJ. Rejection is less common in children undergoing liver
transplantation for hepatoblastoma. Pediatr Transplant 2014;18:52-7. DOI PubMed
53. Lee WS, Grundy R, Milford DV, et al. Renal function following liver transplantation for unresectable hepatoblastoma. Pediatr
Transplant 2003;7:270-6. DOI PubMed
54. Zavala R, Marzouki M, Beaunoyer M, Alvarez F. Glomerular filtration rate in liver transplant for unresectable hepatoblastoma.
Pediatr Transplant 2020;24:e13746. DOI PubMed
55. Hendrickson RJ, Sujka J, Fischer R, Manalang M, Daniel J, Andrews WS. Indications and efficacy of conversion from tacrolimus- to
sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma.
Pediatr Transplant 2019;23:e13369. DOI PubMed
56. Malek MM, Shah SR, Atri P, et al. Review of outcomes of primary liver cancers in children: our institutional experience with
resection and transplantation. Surgery 2010;148:778-82; discussion 782. DOI PubMed
57. Ramos-Gonzalez G, LaQuaglia M, O'Neill AF, et al. Long-term outcomes of liver transplantation for hepatoblastoma: a single-center
14-year experience. Pediatr Transplant 2018:e13250. DOI PubMed
58. Suh MY, Wang K, Gutweiler JR, et al. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma. J Pediatr
Surg 2008;43:1148-52. DOI PubMed
59. Faraj W, Dar F, Marangoni G, et al. Liver transplantation for hepatoblastoma. Liver Transpl 2008;14:1614-9. DOI PubMed
60. Mejia A, Langnas AN, Shaw BW, Torres C, Sudan DL. Living and deceased donor liver transplantation for unresectable
hepatoblastoma at a single center. Clin Transplant 2005;19:721-5. DOI PubMed
61. Al-oabandi W, Jenkinson H, Buckels J, et al. Orthotopic liver transplantation for unresectable hepatoblastoma: a single center's
experience. J Pediatr Surg 1999;34:1261-4. DOI PubMed
62. Sakamoto S, Kasahara M, Mizuta K, et al; Japanese Liver Transplantation Society. Nationwide survey of the outcomes of living
donor liver transplantation for hepatoblastoma in Japan. Liver Transpl 2014;20:333-46. DOI PubMed
63. Tiao GM, Bobey N, Allen S, et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional
resection, and liver transplantation. J Pediatr 2005;146:204-11. DOI PubMed
64. Ng K, Rana A, Masand P, et al. Fatal central nervous system post-transplant lymphoproliferative disease in a patient who underwent
liver transplantation for hepatoblastoma. J Pediatr Gastroenterol Nutr 2018;66:e21-3. DOI PubMed
65. Austin MT, Leys CM, Feurer ID, et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for
Organ Sharing (UNOS) database. J Pediatr Surg 2006;41:182-6. DOI PubMed
66. Zsiros J, Brugieres L, Brock P, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk
hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 2013;14:834-42. DOI PubMed PMC
67. Yang T, Whitlock RS, Vasudevan SA. Surgical management of hepatoblastoma and recent advances. Cancers (Basel) 2019;11:1944.
DOI PubMed PMC
68. Umeda K, Okajima H, Kawaguchi K, et al. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma
after liver transplantation: a single-institute experience. Pediatr Transplant 2018;22:e13113. DOI PubMed
69. Triana Junco P, Cano EM, Dore M, et al. Prognostic Factors for Liver Transplantation in Unresectable Hepatoblastoma. Eur J Pediatr